Progenerative Medical is pleased to announce the enrollment completion of the clinical safety study for its Regenn™ Negative Pressure Therapy System (NPTS).  CEO, Neal Vail, said, “This is a major milestone for us, putting us on track to complete the study later this year followed by submission of our FDA application”.  San Antonio, TX, USA. August 2026.